Literature DB >> 2144854

Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography.

D Novick1, H Engelmann, D Wallach, O Leitner, M Revel, M Rubinstein.   

Abstract

Affinity chromatography of crude human urinary proteins on either human recombinant interleukin-6 (rIL-6) or human recombinant interferon-gamma (rIFN-gamma) or anti IFN-gamma receptor (IFN-gamma-R) monoclonal antibodies (McAb) yielded the two respective soluble receptors in significant amounts. A single sequence of 30 amino acid residues was obtained by N-terminal microsequencing of the protein peak purified in tandem by affinity chromatography on an IL-6 column and reversed-phase high-performance liquid chromatography. This sequence was identical with the predicted N-terminal sequence of IL-6-R as previously reported. The purified IL-6-R retained its biological activity. It was used for the preparation of specific anti IL-6-R monoclonal antibodies. Analysis of the eluted proteins from both IFN-gamma and anti IFN-gamma-R columns by inhibition of solid-phase radioimmunoassay, enzyme-linked immunosorbent assay, sodium dodecyl sulphate-polyacrylamide gel electrophoresis and Western blotting proved the existence of soluble IFN-gamma-R in normal urine. This finding together with the already known presence of soluble TNF receptors and a soluble IL-2 receptor found both in plasma and in urine indicates that release of soluble cytokine receptors into body fluids is a general phenomenon which occurs under normal physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144854     DOI: 10.1016/s0021-9673(01)93767-7

Source DB:  PubMed          Journal:  J Chromatogr


  9 in total

Review 1.  Cytokines, receptors, and inhibitors.

Authors:  G Gehr; T Braun; W Lesslauer
Journal:  Clin Investig       Date:  1992-01

Review 2.  IL-32, a novel cytokine with a possible role in disease.

Authors:  C A Dinarello; S-H Kim
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 3.  Novel targets for interleukin 18 binding protein.

Authors:  C A Dinarello
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

4.  Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.

Authors:  F De Benedetti; M Massa; P Pignatti; S Albani; D Novick; A Martini
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 5.  Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer.

Authors:  J J Patard; D K Chopin; L Boccon-Gibod
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

6.  Proteinase 3 is an IL-32 binding protein.

Authors:  Daniela Novick; Menachem Rubinstein; Tania Azam; Aharon Rabinkov; Charles A Dinarello; Soo-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

7.  Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor.

Authors:  M A Raines; L Liu; S G Quan; V Joe; J F DiPersio; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

8.  Podocytes express IL-6 and lipocalin 2/ neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury.

Authors:  Sarah J Lee; Emily Borsting; Anne-Emilie Declèves; Prabhleen Singh; Robyn Cunard
Journal:  Nephron Exp Nephrol       Date:  2012-12-08

9.  Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro.

Authors:  T Nakajima; S Yamamoto; M Cheng; K Yasukawa; T Hirano; T Kishimoto; T Tokunaga; M Honda
Journal:  Jpn J Cancer Res       Date:  1992-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.